Sign In

Avaleigh Milne

Head of Business Development for Pharma Research and Early Development at Roche

Avaleigh Milne is the Global Head of Business Development Strategy & Practice at Roche.1 She previously held the position of Head of Business Development for Pharma Research and Early Development (pRED) at Roche Pharma Partnering.2 Milne is a key figure in Roche's partnering efforts, playing a significant role in the company's approach to innovation and external collaborations.3

In her current role, Milne is responsible for overseeing Roche's business development strategies and practices on a global scale. She has been involved in various industry events, including delivering a keynote speech at the Swiss Healthcare Licensing Group (Swiss HLG) conference in 2024, where she shared insights on the biopharma ecosystem and the importance of venture capital, biotech, and pharma in sustaining innovation for patients.1

Milne is also an advocate for diversity in leadership within the healthcare industry. She has emphasized the importance of inclusive research and leadership in addressing gaps in health data across gender, race, and ethnicity.4 Her work at Roche contributes to the company's focus on partnering with innovative companies to increase pipeline value and overall patient benefit.3

Related Questions

What are Avaleigh Milne's key achievements at Roche?
How did Avaleigh Milne transition from Oncology Basel Site Head to Head of Business Development?
What strategies does Avaleigh Milne implement for Pharma Research and Early Development at Roche?
How has Avaleigh Milne influenced dealmaking trends in the biotech and pharma industries?
What are some notable projects Avaleigh Milne has led at Roche?
Avaleigh Milne
Avaleigh Milne, photo 1
Avaleigh Milne, photo 2
Add to my network

Location

Switzerland